Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres

European Respiratory Journal

Volumn 35, Issue 5, 2010, Pages 960-968

  Miravitlles, M ^a   Herr, C ^c   Ferrarotti, I ^d   Jardi, R ^b   Rodriguez Frias, F ^b   Luisetti, M ^d   Bals, R ^c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

1 antitrypsin deficiency; Algorithm; Chronic liver disease; Chronic obstructive pulmonary disease; Diagnostic procedures; Emphysema

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; BLOOD SAMPLING; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; DNA SEQUENCE; GENOTYPE; HUMAN; ISOELECTRIC FOCUSING; LABORATORY TEST; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW;

ALGORITHMS; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; BLOOD SPECIMEN COLLECTION; CHRONIC DISEASE; GENETIC TESTING; GERMANY; HUMANS; ISOELECTRIC FOCUSING; ITALY; LIVER DISEASES; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMPHYSEMA; SPAIN;

EID: 77951952370     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00069709     Document Type: Review

References (43)

1. Cox DW. Alpha-1 antitrypsin deficiency. In: Scriver CR, Beaudet AL, Sly WS, et al., Eds. The molecular and metabolic basis of inherited disease. 7th edn. New York, McGraw-Hill, 1995.
2. Blanco I, de Serres FJ, Fernandez-Bustillo E, et al. Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1- antitrypsin deficiency in European countries. Eur Respir J 2006; 2: 77-84. (Pubitemid 43092670)
3. American Thoracic Society/European Respiratory Society Statement. Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168: 818-900.
4. α1-Antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ 1997; 75: 397-415.
5. Hutchison DC. Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z. Respir Med 1998; 92: 367-377.
6. Miravitlles M. Alpha 1-antitrypsin deficiency: epidemiology and prevalence. Respir Med 2000; 94: Suppl. C, S12-S15.
7. De Serres FJ. Worldwide racial and ethnic distribution of alpha1- antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 2002; 122: 1818-1829.
8. Luisetti M, Seersholm N. α1-Antitrypsin deficiency 1. Epidemiology of α1-Antitrypsin deficiency. Thorax 2004; 59: 164-169.
9. Luisetti M, Massi G, Massobrio M, et al. A national program for detection of alpha1-antitrypsin deficiency in Italy. Respir Med 1999; 93: 169-172. (Pubitemid 29090049)
10. Wencker M, Marx A, Konietzko N, et al. Screening for alpha-Pi deficiency in patients with lung diseases. Eur Respir J 2002; 20: 319-324.
11. De La Roza C, Rodríguez-Frías F, Lara B, et al. Results of a case-detection program for alpha-1 antitrypsin deficiency in COPD patients. Eur Respir J 2005; 26: 616-622. (Pubitemid 41448658)
12. Bals R, Koczulla R, Kotke V, et al. Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. Respir Med 2007; 101: 1708-1714. (Pubitemid 46947877)
13. Aboussouan LS, Stoller JK. Detection of alpha-1 antitrypsin deficiency: a review. Respir Med 2009; 103: 335-341.
14. Navickis RJ, Wilkes MM. Update on research, diagnosis and management of alpha1-antitrypsin deficiency. Highlights from the 3rd international Alpha One International Registry Meeting, June 2003, Barcelona, Spain. COPD 2004; 1: 279-292.
15. Campos MA, Wanner A, Zhang G, et al. Trends in the diagnosis of symptomatic patients with α1-antitrypsin deficiency between 1968 and 2003. Chest 2005; 128: 1179-1186.
16. Stoller JK. Alpha-1 antitrypsin deficiency: an under-recognized but important issue for respiratory therapists. Respir Care 2003; 48: 1022-1024.
17. Thelin T, Sveger T, McNeil TF. Primary prevention in a high-risk group: smoking habits in adolescents with homozygous alpha-1-antitrypsin deficiency (ATD). Acta Paediatr 1996; 85: 1207-1212. (Pubitemid 26346017)
18. Wall M, Moe E, Eisenberg J, et al. Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency. J Pediatr 1990; 116: 248-251. (Pubitemid 20056780)
19. McElvaney NG, Stoller JK, Buist AS, et al. Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest 1997; 111: 394-403.
20. Carpenter M, Strange C, Dickson M, et al. Does genetic testing result in behavioural health change? Changes in smoking behaviour following testing for alpha-1 antitrypsin deficiency. Ann Behav Med 2007; 33: 22-28. (Pubitemid 46309936)
21. Campbell EJ. Alpha1-antitrypsin deficiency: incidence and detection program. Respir Med 2000; 94: S18-S21.
22. Zerimech F, Hennache G, Bellon F, et al. Evaluation of a new Sebia isoelectrofocusing kit for alpha 1-antitrypsin phenotyping with the Hydrasys System. Clin Chem Lab Med 2008; 46: 260-263.
23. Costa X, Jardí R, Rodríguez F, et al. Easy method for screening dried blood spot specimens on filter paper for alpha-1 antitrypsin deficiency. Eur Respir J 2000; 15: 1111-1115. (Pubitemid 30399283)
24. Rodriguez F, Jardi R, Costa X, et al. Rapid screening for alpha1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood specimens. Am J Respir Crit Care Med 2002; 166: 814-817.
25. Gorrini M, Ferrarotti I, Lupi A, et al. Validation of a rapid, simple method to measure alpha-1 antitrypsin in human dried blood spots. Clin Chem 2006; 52: 899-901. (Pubitemid 43673276)
26. Ferrarotti I, Scabini R, Campo I, et al. Laboratory diagnosis of alpha1-antitrypsin deficiency. Transl Res 2007; 150: 267-274.
27. Zorzetto M, Tamburnotti C, Maschietto B, et al. A fast amplification-reverse hybridization assay kit to detect the most frequent deficient variants in the alpha-1-antitrypsin gene. Respiration 2002; 69: 81-85. (Pubitemid 34158393)
28. Ferrarotti I, Zorzetto M, Scabini R, et al. A novel method for rapid genotypic identification of alpha 1-antitrypsin variants. Diagn Mol Pathol 2004; 13: 160-163. (Pubitemid 39121741)
29. Kaczor M, Sanak M, Szczeklik A. Rapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a realtime polymerase chain reaction suitable for a large-scale population-based screening. J Mol Diagn 2007; 9: 99-104. (Pubitemid 47322020)
30. Ferrarotti I, Gorrini M, Scabini R, et al. Secondary outputs of alpha1-antitrypsin deficiency targeted detection programme. Respir Med 2008; 102: 354-358. (Pubitemid 351187966)
31. Ferrarotti I, Baccheschi J, Zorzetto M, et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet. 2005; 42: 282-287. (Pubitemid 40380312)
32. Piitulainen E, Sveger T. Effect of clinical and environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha-1-antitrypsin deficiency. Acta Paediatr 1998; 87: 1120-1124. (Pubitemid 28538420)
33. Corbo GM, Forastiere F, Agabti N, et al. Passive smoking and lung function in a(1)-antitrypsin heterozygote school-children. Thorax 2003; 58: 237-241.
34. Tobin MJ, Cook PJ, Hutchison DC. Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest 1983; 77: 14-27. (Pubitemid 13183041)
35. Larsson C. Natural history and life expectancy in severe alpha-1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978; 204: 345-351. (Pubitemid 9051719)
36. Janus ED, Phillips NT, Carrell RW. Smoking, lung function, and alpha 1- antitrypsin deficiency. Lancet 1985; 1: 152-154. (Pubitemid 15152477)
37. Seersholm N, Kok-Jensen A, Dirksen A. Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ. Am J Respir Crit Care Med 1995; 152: 1922-1925.
38. Piitulainen E, Eriksson S. Decline in FEV1 related to smoking status in individuals with severe α1-antitrypsin deficiency (PiZZ). Eur Respir J 1999; 13: 247-251. (Pubitemid 29086815)
39. Tirado-Conde G, Lara B, Miravitlles M. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency. Ther Adv Respir Dis 2008; 2: 13-21. (Pubitemid 351565980)
40. Snyder MR, Katzmann JA, Butz ML, et al. Diagnosis of alpha-1-antitrypsin deficiency: an algorithm of quantification, genotyping, and phenotyping. Clin Chem 2006; 52: 2236-2242.
41. Bornhorst JA, Procter M, Meadows C, et al. Evaluation of an integrative diagnostic algorithmfor the identification of people at risk for alpha1-antitrypsin deficiency. Am J Clin Pathol 2007; 128: 482-490. (Pubitemid 47479982)
42. Rahaghi F, Ortega I, Rahaghi N, et al. Physician alert suggesting alpha-1 antitrypsin deficiency testing in pulmonary function test (PFT) results. COPD 2009; 6: 26-30.
43. Stockley RA, Luisetti M, Miravitlles M, et al. Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development. Eur Respir J 2007; 29: 582-586. (Pubitemid 46379103)